These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease. Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994 [TBL] [Abstract][Full Text] [Related]
15. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I). Hegele RA; Volpé R J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162 [TBL] [Abstract][Full Text] [Related]
16. Iodine-131 treatment of Graves' disease using modified early iodine-131 uptake measurements in therapy dose calculations. Hayes AA; Akre CM; Gorman CA J Nucl Med; 1990 Apr; 31(4):519-22. PubMed ID: 2324829 [TBL] [Abstract][Full Text] [Related]
17. A simplified method for treating Graves' disease with radioactive 131I. Masri MT; Menne M; Rooney BL; Caplan RH Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797 [TBL] [Abstract][Full Text] [Related]
18. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient. Das PK; Wherrett D; Dror Y Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of diffuse hyperthyroidism using radioactive iodine]. Latković I; Krpan N; Simonović I Lijec Vjesn; 1975 Feb; 97(2):72-7. PubMed ID: 1174256 [No Abstract] [Full Text] [Related]